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Genes Expressed in Response to PRRSV
Derek B. Petry
Rodger K. Johnson
Joan Lunney1
Summary and Implications
Gene maps of livestock are rapidly 
being developed and have led to an 
explosion of knowledge in recent years 
about genes affecting economic traits.­ 
One potential application of this 
information that would have major 
economic value is in selection of live-
stock for resistance to disease.­ Even 
though much has been learned about 
Porcine Reproductive and Respiratory 
Syndrome Virus (PRRSV) since it 
was first identified, PRRSV continues 
to cause significant economic losses in 
many herds.­ Traditional approaches 
to manage PRRSV can be effective, 
but may be costly and have not always 
resulted in permanent control.­ This 
is a disease for which application of 
molecular genetic knowledge to select 
for resistance would h­ave significant 
economic advantages.­ An experiment 
was initiated at Nebraska to investi-
gate possible genetic variation among 
pigs in response to PRRSV.­ Pigs 
from two populations were infected 
with PRRSV, responses over 14 days 
were recorded, and tissues were col-
lected at necropsy for gene expression 
studies.­ Phenotypic data, including 
body weights and rectal temperatures, 
viremia, and lung lesion scores, pro-
vided substantial evidence that genetic 
variation in response to PRRSV ex-
ists.­ With that knowledge, we devel-
oped an index of high (H) and low (L) 
responders, indicating susceptible and 
resistant phenotypes, and measured 
expression differences in lung and 
bronchial lymph node of 11 immune 
function genes between H and L pigs.­ 
Ten of these genes, involving both in-
nate and acquired immune function, 
were expressed differently in lung 
and/or lymph tissue.­ They tended to 
be up-regulated (expressed at greater 
levels) in H pigs.­ We demonstrated 
that genetic variation in response to 
PRRSV exists and that both innate 
and acquired genes are involved.­ We 
have not yet determined whether selec-
tion for the immune function genes 
involved or levels of the proteins they 
produce will be effective in selecting 
for PRRSV resistance.­ Results will 
be helpful in additional investigations 
aimed at developing methods to select 
for resistance to PRRSV.­
Introduction
The	National	Pork	Board	has	
estimated	that	disease	due	to	the	
Porcine	Reproductive	and	Respi-
ratory	Syndrome	Virus	(PRRSV)	
causes	annual	losses	of	approxi-
mately	$560	million	to	U.S.	pork	
producers.	To	combat	PRRSV,	
the	Coordinated	Agricultural	
Program	(CAP)	grant	awarded	
to	researchers	in	the	industry	by	
USDA	National	Research	Initiative	
(NRI),	a	major,	multi-disciplinary	
initiative	to	eradicate	PRRSV,	was	
implemented.
One	objective	of	the	NRI	CAP	
grant	is	to	investigate	the	possibil-
ity	of	genetically	modifying	the	
pig	as	a	means	to	control	PRRSV.	
The	hypothesis	is	that	genetic	
variation	in	response	to	PRRSV	
exists,	that	the	genes	responsible	
for	th­is	variation	can	be	identified,	
and	that	selection	on	these	genes	
will	be	effective	in	developing	
lines	of	pigs	resistant	to	PRRSV.	
An	experiment	was	initiated	at	the	
University	of	Nebraska	to	test	this	
hypothesis.	The	objectives	were	
1)	to	determine	whether	genetic	
variation	exists,	2)	to	identify	traits	
that	differentiate	animals	that	
respond	differently	to	PRRSV,		
3)	to	build	the	phenotypic	and	
genotypic	records	to	quantify	
genetic	variation	between	ani-
mals	and	4)	to	identify	the	genes	
involved	in	the	response.
Nebraska PRRSV Infection
Experiment
The	description	of	the	experi-
ment	and	biological	responses	
relating	to	objectives	1	to	3	were	
reported	in	the	2004 Nebraska Swine 
Report.­	An	overview	is	included	
here.
Pigs	of	each	of	two	popula-
tions	were	infected	with	PRRSV	
and	their	phenotypic	responses	
over	a	14-day	period	were	
recorded.	A	total	of	200	pigs	from	
the	Nebraska	Index	line	(I),	a	
Large	White-Landrace	composite	
population	that	has	been	selected	
for	increased	litter	size	for	20	gen-
erations,	and	200	pigs	from	a	cross	
of	Hampshire	and	Duroc	lines	
(HD)	that	have	been	selected	for	
rate	and	efficiency	of	lean	growth­	
were	used.	Line	I	pigs	were	born	
in	the	University	of	Nebraska	
swine	research	herd,	whereas	HD	
pigs	were	obtained	from	a	com-
mercial	farm.	Neither	farm	had	
experienced	disease	from	PRRSV	
and	pigs	from	both	herds	had	
tested	negative	for	the	presence	of	
PRRSV	by	PCR	methods	and	for	
PRRSV	serum	antibodies	by	the	
ELISA	test.	Pigs	represented	a	total	
of	83	sires	and	163	dams.
Pigs	were	transported	at	an	
average	age	of	23	days	to	the	Uni-
versity	of	Nebraska	Veterinary	and	
Biomedical	Sciences	(VBS)	Animal	
Research	Facility	and	placed	in	
environmentally	controlled	rooms,	
two	pens	per	room,	and	12	to	
13	pigs	per	pen.	One	room	was	
randomly	assigned	for	treatment	
and	the	pigs	were	inoculated	intra-
nasally	with	2	ml	(1	ml	per	nostril)	
of	105	CCID50	(cell	culture	infec-
tious	dose	50%	per	ml)	of	PRRSV	
strain	97-7985	supplied	by	Dr.	Fer-
nando	Osorio.	Pigs	in	the	other	iso-
lated	room	were	littermates	to	the	
infected	pigs	and	served	as	con-
trols.	Data	were	collected	on	days	
0,	4,	7	and	14	post-inoculation.	Pigs	
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were	killed	at	day14,	necropsy	was	
performed,	and	samples	of	several	
tissues	were	colleted	for	gene	ex-
pression	experiments.
Phenotypic Traits Measured
Body	temperature	by	rectal	
probe,	body	weight,	and	blood	
draws	were	collected	and	recorded	
just	before	inoculation	(day	0)	and	
4,	7,	and	14	days	after	inoculation.	
At	necropsy,	samples	of	lung,	
bronchial	lymph	node,	and	spleen	
were	collected	and	stored	at	-80oC.	
Viremia	(CCID50/ml),	a	measure	
of	each	pig’s	ability	to	replicate	
the	virus,	was	measured	in	serum	
collected	at	days	4,	7,	and	14,	and	
in	lung	and	bronchial	lymph	node	
collected	at	necropsy.	An	ELISA	test	
was	conducted	on	serum	samples	
collected	at	d14	to	determine	the	
level	of	PPRSV	antibody	in	infected	
pigs	and	to	test	for	possible	cross	
contamination	in	uninfected	pigs.
Lungs	were	scored	for	the	
presence	of	pneumonia	(yes	(1)	
or	no	(0)).	Sections	of	lung	were	
examined	by	light	microscopy	and	
scored	on	a	scale	of	1	to	3.	Lungs	
receiving	a	score	of	1	had	no	lesions	
or	had	mild	multifocal	interstitial	
pneumonia.	A	score	of	2	was	given	
to	lung	sections	that	had	moderate	
interstitial	pneumonia	involving	
less	than	50%	of	the	area	of	the	sec-
tion.	A	score	of	3	was	given	to	lung	
sections	that	had	greater	than	50%	
involvement	of	severe	interstitial	
pneumonia.	If	present,	lesions	sug-
gestive	of	mycoplasma hyopneumonae	
and	infectious	bacterial	pneumonia	
were	recorded.
Identifying resistant and susceptible 
pigs
Principal	component	(PC)	
analysis,	a	multivariate	procedure,	
was	used	to	identify	pigs	in	the	
outermost	tails	of	the	distribution	
of	response	variables.	This	proce-
dure	combined	all	variables	into	an	
index	in	which	traits	were	weight-
ed	according	to	their	contribution	
to	total	variation.	Traits	included	
were	viremia	at	4,	7,	and	14	days	
post-infection	(dpi),	weight	change	
from	0	to	4,	4	to	7,	and	7	to	14	dpi,	
rectal	temperature	change	from	0	
to	4,	4	to	7,	and	7	to	14	dpi,	lung	
and	bronchial	lymph	node	viremia,	
and	severity	of	lung	lesions.	Pigs	
receiving	high	PC	values	had	high	
viremia	and	high	symptoms	of	
PRRSV	(H)	and	pigs	with	low	PC	
values	had	low	viremia	and	low	
symptoms	(L).	Based	on	the	PC	
analysis,	7	H	and	7	L	pigs	in	each	
population	and	their	uninfected	
littermates	(total	of	56	pigs)	were	
used	in	a	2*2*2	factorial	design	that	
included	class	(pigs	classed	as	H	or	
L	responders),	line	(I	or	HD),	and	
treatment	(infected	or	uninfected).
Gene expression analyses
RNA	from	the	lung	and	bron-
chial	lymph	node	(BLN)	tissues	of	
the	56	pigs	was	extracted	and	gene	
expression	was	evaluated	with	
RT-PCR.	Gene	expression	cycle	
thresholds	(Ct),	which	are	directly	
related	to	the	initial	amount	of	
target	DNA	present,	were	re-
corded.	A	low	Ct	value	means	
that	the	expression	level	of	that	
gene	was	high	because	fewer	PCR	
cycles	were	required	to	reach	the	
threshold,	and	vice	versa,	a	high	
Ct	value	means	that	the	expres-
sion	level	was	low	because	it	took	
more	cycles	to	reach	the	threshold.	
Thus,	samples	producing	low	Ct	
values	had	more	cDNA,	indicat-
ing	greater	expression	of	the	gene,	
than	those	with	high	values.
Five	genes	with	innate	
immune	function,	five	genes	with­	
acquired	immune	function,	one	
regulator	gene,	and	a	housekeep-
ing	gene	to	monitor	experimental	
procedures	were	evaluated.	Innate	
immunity	is	the	basic	resistance	to	
disease	that	an	animal	possesses.	
It	is	th­e	first	line	of	defense	against	
infection.	Responses	are	immedi-
ate	and	broad-spectrum,	without	
memory,	so	there	is	no	lasting	
protective	immunity.	Acquired	
immunity	on	the	other	hand	oc-
curs	in	response	to	infection	and	
is	often	called	adaptive,	as	the	
immune	system	must	adapt	itself	
to	previously	unseen	molecules.	
Responses	are	slower,	but	in	the	
case	of	certain	organisms,	this	type	
of	immunity	can	be	long-lasting	as	
the	individual	may	be	immunized	
against	certain	organisms.
Genes involved in Innate Immunity
•	Interferon	alpha	(IFNA)	
–	induces	an	antiviral	response	or	
resistance	to	viral	replication	by	
binding	to	th­e	interferon	α/α	recep-
tor.	Once	bound,	IFNA	helps	acti-
vate	the	JAK-STAT	pathway,	which	
in	turn	induces	the	transcription	of	
several	genes.	Genes	activated	by	
IFNA	contribute	to	the	inhibition	of	
viral	replication.	The	IFNA	gene	is	
on	chromosome	4.
•	Interleukin	1	beta	(IL1B)	
-	Produced	by	activated	macro-
phages,	IL-1	stimulates	thymocyte	
proliferation	by	inducting	IL-2	
release,	B-cell	maturation	and	
proliferation	and	fibroblast	growth­	
factor	activity.	The	IL1B	gene	is	on	
chromosome	3.
•	Interleukin	6	(IL6)	-	is	a	
cytokine	with	a	wide	variety	of	
biological	functions:	it	plays	an	
essential	role	in	th­e	final	differen-
tiation	of	B-cells	into	IG-secreting	
cells;	it	induces	myeloma	and	
plasmacytoma	growth,	nerve	cell	
differentiation	in	hepatocytes,	
and	acute	phase	reactants.	IL6	is	
located	on	chromosome	9.
•	Interleukin	8	(IL8)	-	is	a	che-
motactic	factor	that	attracts	neu-
trophils,	basophils	and	T-cells	but	
not	monocytes.	It	is	also	involved	
in	neutrophil	activation	and	is	
released	from	several	cell	types	
in	response	to	an	inflammatory	
response.	IL8	is	located	on	chro-
mosome	8.
•	Colony	stimulating	factor	2	
(CSF2)	–	named	for	their	ability	to	
induce	the	formation	of	distinct	
hematopoietic	cell	lines.	CSF2	is	
located	on	chromosome	5.
Genes involved in Th1 (acquired) im-
mune response
•	Interferon	gamma	(IFNG)	
-	produced	by	lymphocytes	and	
activated	by	specific	antigens	or	
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mitogens.	IFN-gamma,	in	addi-
tion	to	having	antiviral	activity,	
has	important	immunoregulatory	
functions.	It	is	a	potent	activator	of	
macrophages,	and	has	anti-prolif-
erative	effects	on	transformed	cells	
and	it	can	potentiate	the	antiviral	
and	anti-tumor	effects	of	the	type	
I	interferons.	IFNG	is	located	on	
chromosome	5.
•	Interleukin	12	beta	(IL12B)	
–	functions	to	stimulate	the	
synthesis	of	interferon-gamma	
by	T-lymphocytes	and	NK	cells;	
increases	the	killing	activity	of	
CTLs	and	NK	cells;	and	stimu-
lates	the	differentiation	of	naive	
T4-lymphocytes	into	interferon-
gamma	producing	Th1	cells.	It	is	
produced	mainly	by	macrophages	
and	dendritic	cells.	IL12B	is	located	
on	chromosome	5.
•	Interleukin	15	(IL15)	–	stimu-
lates	NK	cell	proliferation	and	
proliferation	of	T-lymphocytes.	
IL-15	is	produced	by	various	cells	
including	macrophages.	IL15	is	
located	on	chromosome	8.
•	Signal	transducer	and	acti-
vator	of	transcription	1-alpha	
(STAT1)	–	binds	to	phosphorylated	
tyrosine	residues	playing	an	essen-
tial	role	in	the	signaling	pathways	
of	a	variety	of	cytokines.	STAT1	is	
located	on	chromosome	15.
•	Tumor	necrosis	factor	
(TNF)	–	it	is	a	cytokine	that	
binds	to	TNFRSF1A/TNFR1	and	
TNFRSF1B/TNFBR.	It	is	mainly	se-
creted	by	macrophages	and	can	in-
duce	cell	death	of	certain	tumor	cell	
lines.	It	is	a	potent	pyrogen	causing	
fever	by	direct	action	or	by	stimula-
tion	of	interleukin	1	secretion	and	
is	implicated	in	the	induction	of	
cachexia.	Under	certain	conditions	
it	can	stimulate	cell	proliferation	
and	induce	cell	differentiation.	TNF	
is	located	on	chromosome	7.
Genes involved in the T-regulatory 
immune function
•	Interleukin	10	(IL10)	
–	stimulates	proliferation	of	B	cells,	
thymocytes,	and	mast	cells.	It	also	
antagonizes	generation	of	the	Th1	
subset	of	helper	T	cells	so	it	is	an	
inhibitor	of	activated	macrophages	
and	dendritic	cells.	As	such,	it	
regulates	innate	immunity	and	
cell-mediated	immunity.	IL10	is	
located	on	chromosome	1.
Housekeeping gene
•	Ribosomal	protein	L32	
(RPL32)	–	ubiquitous	protein	
found	throughout	the	body.	
This	gene	is	used	to	determine	
if	protocols	were	working	prop-
erly	because	all	pigs	should	have	
approximately	the	same	level	of	
the	protein,	however	levels	may	
differ	across	tissues.	RPL32	is	
found	on	several	chromosomes.
Results
There	was	substantial	evidence	
for	genetic	variation	as	pigs	of	the	
two	populations	had	distinctly	
different	responses	to	PRRSV	(see	
the	2004	Nebraska	Swine	Report).	
With	that	evidence	in	hand,	we	
developed	the	Principal	Compo-
nent	Index	to	describe	susceptible	
and	resistant	pigs.	The	seven	high-
est	and	lowest	responders	in	each	
population	and	their	littermates	
were	used	to	determine	whether	
specific	immune	function	genes	
were	expressed	differently	in	tis-
sues	of	these	pigs.
Table	1	contains	the	overall	
line	means	for	individual	traits	and	
the	means	of	the	seven	pigs	in	each	
line	classified	as	susceptible	(H,	
high	viremia	and	high	symptoms	
of	PRRSV)	or	resistant	(L,	low	vire-
mia	and	low	symptoms).	All	pigs	
replicated	PRRSV	as	evidenced	by	
elevated	serum	viremia	values	at	
day	4.	Serum	viremia	of	L	class	pigs	
in	Line	I	dropped	sharply	at	day	7	
and	declined	to	values	near	zero	by	
day	14,	whereas	serum	viremia	of	
H	pigs	remained	high	throughout.	
In	both	lines,	L	pigs	showed	im-
mediate	symptoms	of	PRRSV	with	
slightly	decreased	weight	gain	and	
increased	temperature,	but	they	re-
covered	quickly	and	gained	weight	
at	near	normal	rates	and	had	near	
normal	temperatures	from	day	7	
to	14,	whereas	H	pigs	had	high	
temperatures,	with	the	exception	of	
temperature	of	HD	pigs,	from	day	
7-14,	and	low	or	negative	weight	
gain	during	each	period.	The	gen-
eral	nature	of	the	response	was	
similar	in	both	lines,	but	the	dif-
ference	between	H	and	L	pigs	was	
greater	in	I	than	in	HD,	suggesting	
resistant	I	pigs	(the	L	class)	had	a	
stronger	innate	immune	response	
to	PRRSV	than	HD	pigs.	This	differ-
ence	in	response	between	lines	was	
supported	by	the	gene	expression	
data	(see	below).
Differences	in	gene	expression	
levels	in	lung	and	bronchial	lymph	
nodes	between	infected	and	unin-
fected	pigs,	between	susceptible	(H)	
and	resistant	(L)	pigs	that	had	been	
infected	with	PRRSV,	and	between	
uninfected	littermates	of	H	and	L	
pigs	are	in	Table	2.	Gene	expres-
sion	is	measured	by	the	number	
of	cycles	to	produce	a	predefined	
threshold	level	of	cDNA,	the	com-
plementary	DNA	of	the	RNA	har-
vested	from	the	tissue.	Each	cycle	
doubles	the	amount	from	the	previ-
ous	cycle.	Therefore,	differences	of	
1	Ct	represent	a	two-fold	difference	
in	cDNA,	differences	of	2	represent	
a	four-fold	difference,	etc.
Th­e	first	contrast	(I	–	UI)	con-
trasts	gene	expression	between	
infected	(+)	and	uninfected	(-)	pigs.	
It	shows	which	immune	function	
genes	were	stimulated	to	produce	
RNA	in	response	to	PRRSV.	Seven	
of	the	11	genes	studied	responded	
in	lung	tissue	(P	<	0.05)	and	all	
were	up-regulated	as	it	took	fewer	
Ct	cycles	to	produce	the	threshold	
level	of	cDNA.	Three	genes	(IL1B,	
IL8,	and	CSF2)	are	innate	immu-
nity	genes,	and	four	(IFNG,	IL12B,	
STAT1,	and	TNF)	are	part	of	the	
acquired	immune	response.	Each	
of	these	genes	except	IL1B	also	was	
up-regulated	in	bronchial	lymph	
nodes.	Three	additional	genes	also	
were	up-regulated	in	lymph	tissue	
(	INFA,	IL10,	and	IL6).	Therefore,	
every	gene	studied	except	IL15,	
including	the	regulator	gene	IL10,	
was	expressed	in	greater	amounts	
in	either	or	both	lung	and	lymph	
(Continued on next page)
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tissue	in	response	to	PRRSV.
The	next	contrasts	(H	-	L)	are	
between	pigs	classed	as	suscep-
tible	(H)	and	resistant	(L).	It	was	
done	both	in	infected	(+)	and	in	
uninfected	littermates	(-)	to	deter-
mine	whether	resistance	occurred	
because	pigs	had	a	greater	capacity	
to	respond	to	the	virus	(measured	
in	infected	pigs),	or	whether	there	
was	naturally	greater	expression	
of	the	gene	even	in	the	absence	of	
virus	(measured	in	uninfected	lit-
termates).
Susceptible	pigs	(H	class)	had	
greater	expression	of	four	genes	
in	both	lung	and	lymph.	Two	of	
these	genes	are	involved	in	innate	
immunity	(IL1B	and	IL8),	INFG	is	
involved	with	acquired	immunity,	
and	IL10	is	a	regulator	gene.	An	
additional	acquired	immunity	
gene,	STAT1,	had	greater	expres-
sion	in	lung.	In	all	cases,	resistant	
pigs	(L	class)	had	less	expression	
of	these	genes.	For	two	of	these	
genes	(INFG	and	IL10),	uninfected	
littermates	of	resistant	pigs	also	
had	lower	expression	levels	than	
uninfected	susceptible	pigs.	This	
suggests	that	the	expression	of	
these	genes	may	be	an	inherent	
difference	between	H	and	L	pigs	
that	exists	without	the	stimulus	
of	PRRSV.	There	were	no	similar	
cases	in	lymph	tissue.	Therefore,	
most	of	the	differences	in	gene	ex-
pression	between	susceptible	and	
resistant	pigs	probably	occurred	as	
a	response	to	PRRSV.
Interactions
Only	a	few	interactions	of	
class	(resistant	vs	susceptible)	with	
genetic	line	existed,	indicating	that	
the	general	nature	of	expression	
differences	between	H	and	L	pigs	
was	consistent	across	lines.	How-
ever,	several	significant	interactions	
of	genetic	line	with	treatment	
(infected	vs	uninfected)	existed.	
Interaction	existed		
(P	<	0.05)	for	expression	of	IFNG,	
IL12B,	Il8,	and	TNF	in	lung,	and	for	
IFNA	in	lymph	node.	The	general	
nature	of	these	suggested	that	Line	
Table 1. Overall line means and means for the seven high (H) and low (L) responders 
within each line based on Principal Component Index.
	 Line	I	 Line	HD
Item	 Overalla	 Hb	 Lc	 Overalla	 Hb	 Lc
Viremia,	log10	CCID50/ml
Serum,	day	4	 4.17	 4.39	 4.11	 4.54	 5.11	 3.10
Serum,	day	7	 3.91	 4.47	 3.20	 4.40	 5.13	 3.64
Serum,	day	14	 3.00	 4.49	 0.50	 3.59	 5.29	 2.51
Lung	 3.96	 5.07	 2.40	 4.45	 4.71	 4.21
Lymph	 2.55	 3.33	 1.31	 3.12	 3.70	 2.66
Body	weight	change,	lb
Day	0	to	4	 0.71	 0.18	 1.28	 0.64	 -0.09	 1.17
Day	4	to	7	 0.73	 -0.02	 2.03	 0.13	 -0.40	 0.82
Day	7	to	14	 2.98	 0.68	 4.87	 1.57	 -1.26	 3.97
Rectal	temperature	change,	oF
Day	0	to	4	 1.66	 1.96	 .59	 3.17	 1.42	 3.49
Day	4	to	7	 1.04	 1.80	 1.19	 1.48	 2.45	 -0.11
Day	7	to	14	 -0.30	 0.65	 -1.81	 -0.65	 -5.11	 -0.47
Lung	lesion	score
	 1.26	 1.57	 1.00	 1.96	 1.57	 2.00
aOverall	line	mean	(n	=	100).
bMean	of	7	pigs	classed	as	high	responders	based	on	principal	component	index.
cMean	of	7	pigs	classed	as	low	responders	based	on	principal	component	index.
I	had	a	greater	innate	response	to	
PRRSV	whereas	Line	HD	had	a	
greater	acquired	response.
As	an	example	of	these	inter-
actions,	expression	of	the	innate	
gene	IFNA	in	lymph	was	nearly	
identical	in	infected	and	uninfected	
I	pigs	(30.3	vs	30.4	Ct),	whereas	the	
difference	was	more	than	two-fold	
between	infected	and	uninfected	
HD	pigs	(30.5	vs	29.3).	Infection	
reduced	expression	of	INFA	in	HD,	
but	had	no	effect	in	I	pigs.
Expression	of	the	IFNG	gene	
involved	in	acquired	immunity	is	
another	example.	The	Ct	values	
for	uninfected	and	infected	I	pigs	
were	27.3	and	26.2,	respectively,	
whereas	values	for	uninfected	and	
infected	HD	pigs	were	28.1	and	
24.9,	respectively.	Infection	stimu-
Table 2. Differences in gene expression levels (Ct values) between infected (I) and 
uninfected (UI) pigs, between infected susceptible (H+, high responders) and 
infected resistant (L+, low responders), and between uninfected littermates (-) of 
H and L class pigs.
	 Lung	 Bronchial	lymph	node
Gene	 I	-	UI	 H+	-	L+	 H-	-	L-	 I	-	UI	 H+	-	L+	 H--	L-
IFNA	 -0.03	 -0.88	 -0.71	 -0.53**	 -0.60	 -0.48
IFNG	 -2.15**	 -2.40**	 -1.36**	 -2.18**	 -1.43**	 0.25
IL15	 -0.12	 -1.51	 -0.76	 -0.15	 -1.73	 -0.82
STAT1	 -0.82**	 -1.59*	 -0.88	 -0.82**	 -0.56	 0.00
IL1B	 -2.03**	 -1.38*	 0.21	 -0.38	 -1.66**	 0.89
IL12B	 -1.22**	 -0.31	 1.02	 -0.69*	 -0.16	 0.66
CSF2	 -1.10**	 -0.71	 0.28	 -0.73**	 0.23	 0.48
IL8	 -2.26**	 -1.80*	 -0.24	 -2.02**	 -2.17*	 0.98
IL10	 -0.43	 -2.53**	 -1.75**	 -0.68*	 -1.76*	 -0.42
IL6	 -0.06	 -0.81	 -0.50	 -0.56*	 -0.60	 0.14
TNF	 -0.68*	 -1.36	 -0.44	 -0.67**	 -0.08	 0.64
lated	a	significantly	greater	expres-
sion	of	IFNG	in	HD	pigs.
In	general	these	interactions	
supported	the	suggestion	from	the	
phenotypic	data	that	I-pigs	had	a	
stronger	innate	response	to	PRRSV,	
whereas	HD	pigs	had	a	stronger	
acquired	response.	All	pigs	ex-
hibited	symptoms	of	PRRSV,	but	
due	to	greater	innate	immunity,	I	
pigs	recovered	more	quickly	and	
had	greater	weight	gain	and	lower	
rectal	temperatures,	especially	from	
day	7	to	14,	than	HD	pigs.
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